Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations

Autor: Oizumi, Satoshi, Sugawara, Shunichi, Minato, Koichi, Harada, Toshiyuki, Inoue, Akira, Fujita, Yuka, Maemondo, Makoto, Watanabe, Satoshi, Ito, Kazuhiko, Gemma, Akihiko, Demura, Yoshiki, Fukumoto, Shinichi, Isobe, Hiroshi, Kinoshita, Ichiro, Morita, Satoshi, Kobayashi, Kunihiko, Hagiwara, Koichi, Aiba, Keisuke, Nukiwa, Toshihiro
Zdroj: In ESMO Open 2018 3(2)
Databáze: ScienceDirect